Anupam Rasayan India Ltd
Financial trend (54/100) does the heavy lifting; valuation (16/100) is the drag.
ExpensiveOvervaluedOur blended model reads Anupam Rasayan India Ltd as a Sell at 33/100. On 83.3x trailing earnings it sits pricier than the Chemicals median of about 41.0x. The price is about 12% below its 52-week high of ₹1,376 and 14% above the low of ₹1,064.7. Financial health scores 96/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹1,065 implies about 12% downside across 6 analysts. It clears 3 of 13 investability checks, with durability 40, valuation 24 and momentum 26 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹725.64.
Analyst views
1-year price
EOD · 2026-07-2952-week range
-11.74% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell33Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 5.8%
- Pass: Low debt (D/E < 0.5): 0.40x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 28%
- Fail: Earnings growing: -8%
- Fail: Net margin ≥ 10%: 7.2%
- Fail: Current ratio > 1.5: 1.43
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 4.85
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter85.0%
- Institutions0.5%
- Public & other14.5%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Financially solid — Altman Z 4.85.
Opportunities
- Revenue growing (28% YoY).
Bear case
Weaknesses
- Low return on equity (5.8%).
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
- Rich valuation versus sector peers.
- Trades ~25% above our estimated fair value.
About Anupam Rasayan India Ltd
Anupam Rasayan India manufactures custom synthesis specialty chemicals across life science and other segments, serving agrochemical, pharmaceutical, and related industries. The company operates manufacturing facilities in India, Europe, Japan, Singapore, China, and North America, producing agro intermediates, agro active ingredients, anti-bacterial compounds, and ultraviolet protection intermediates.
Anupam Rasayan India Ltd — frequently asked questions
Is Anupam Rasayan India Ltd a buy, hold or sell?
StocksWizard currently rates Anupam Rasayan India Ltd (ANURAS) a Sell, based on a blended score of 33/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Anupam Rasayan India Ltd's fair value?
Our blended DCF and relative-valuation model estimates Anupam Rasayan India Ltd's fair value at about ₹907.05, versus a current price of ₹1,214.4 — roughly 25% downside. On that basis the stock looks overvalued by 25%.
Is Anupam Rasayan India Ltd financially healthy?
Anupam Rasayan India Ltd scores 96/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Anupam Rasayan India Ltd's share price performed?
Anupam Rasayan India Ltd is down 10% over three months, and last traded at ₹1,214.4. Past performance doesn't predict future returns.
More in Chemicals
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.